APOHEALTH DESLORATADINE desloratadine 5 mg tablet blister pack (new formulation)

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

desloratadine, Quantity: 5 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: dibasic sodium phosphate; lactose monohydrate; pregelatinised starch; magnesium stearate; maize starch; colloidal anhydrous silica; microcrystalline cellulose; hydrogenated cottonseed oil; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; indigo carmine aluminium lake

Administration route:

Oral

Units in package:

5, 3, 14, 42, 60, 2, 15, 50, 30, 10, 25, 28, 40, 45, 20, 7

Prescription type:

(S2) Pharmacy Medicine

Therapeutic indications:

The rapid relief of symptoms associated with seasonal allergic rhinitis. The nasal symptoms of allergic rhinits include rhinorrhoea, sneezing and nasal itching. Allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate. The relief of symptoms associated with perennial allergic rhinitis. The symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria.

Product summary:

Visual Identification: Blue, round, biconvex tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2022-03-16